Our mission is to unlock the immune system to prevent disease.
We are digitizing biology using novel computational methods and machine learning to give a full view of an individual’s immune system. By digitizing immune data, we accelerate discovery and development for therapies and diagnostics*. We envision a future where understanding the state of your immune system is part of everyday life.
Seeded at Fred Hutch. Incubated at AI2.
Our history is rooted in work our founders pioneered at the Fred Hutch Institute for Cancer Research. There, they developed the foundational capabilities that enable the computational analysis of single-cell data leveraged worldwide. Through this work, they were able to foresee a fundamental shift in how we leverage single-cell data. To accelerate and realize the full impact of AI-driven analysis, we incubated at AI2 and raised our seed funding led by Madrona Ventures. We are proud of our Pacific Northwest roots and are excited to grow globally.
Meet the team.
We are bringing together the brightest minds from leading tech, health and bio science companies. Our belief: Diversity brings divergent ideas and problem solving approaches that drive innovation.
Ali Ansary
Amalia Okrent
Andrew McDavid, PhD
Arthur Maloy
Arpan Neupane, PhD
Ashley Wilson, PhD
Brandon Stilson
Bryan Myers
Catherine Sanders
Chelsea Haupt, PhD
Cherie Green
Corrie Ortega PhD
D. Ely Bair
Denise Allen, PhD
Evan Greene, PhD
& Co-Founder
Fritz Lekschas, PhD
Greg Finak, PhD
Jon Lee
Kurt Van Gunst
Malisa Smith
Mike Comeau
Mike Jiang
Rahmat Raji
Raphael Gottardo, PhD
Sheridan Grant
Proudly Backed By
* Data provided by Ozette is to be used for exploratory research purposes only, not to be used to make clinical decisions such as diagnosis, prevention, monitoring, treatment, alleviation of disease.